GMO Benchmark-Free Allocation Fund Class IV GBMBX

Medalist Rating as of | See GMO Investment Hub
  • NAV / 1-Day Return 33.52  /  −0.18 %
  • Total Assets 2.6B
  • Adj. Expense Ratio
    1.300%
  • Expense Ratio 0.620%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Global Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity High/Limited
  • Status Open
  • TTM Yield 3.86%
  • Turnover 11%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:11 AM GMT+0

Morningstar’s Analysis GBMBX

Will GBMBX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A consistent, if unconstrained, execution of valuation-driven investing.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark-Free Allocation stands apart from peers as a pure expression of the firm’s valuation-focused investment philosophy. An expert duo backed by robust resources shepherds the strategy, but the unconstrained approach can face unique challenges.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GBMBX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us 2yr Note (Cbt)

34.11 838M
Government

Contra Derivatives - Swaps

22.99 565M

Us 5yr Note (Cbt)

13.46 331M
Government

United States Treasury Notes 3.77%

12.01 295M
Government

10 Year Treasury Note Future June 26

7.57 186M
Government

United States Treasury Notes 3.86%

5.89 145M
Government

Ultra 10 Year US Treasury Note Future June 26

4.95 122M
Government

United States Treasury Notes 3.83%

4.86 119M
Government

Future on TOPIX

−3.58 −88M

Contra Derivatives - Futures

−54.21 −1B

Sponsor Center